Miyake, K <br/><br/>
Selective killing of human immunodeficiency virus-infected cells by targeted gene transfer and inducible gene expression using a recombinant human immunodeficiency virus vector.  [electronic resource] 

 -  Human gene therapy  Feb 2001 
 - 227-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1043-0342 
<br/><br/><label>Standard No.: </label>10.1089/10430340150218378  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiviral Agents--pharmacology<br/>CD4-Positive T-Lymphocytes--metabolism<br/>COS Cells<br/>Cell Death<br/>Cell Line<br/>Coloring Agents--pharmacology<br/>Dose-Response Relationship, Drug<br/>Ganciclovir--pharmacology<br/>Gene Transfer Techniques<br/>Genetic Vectors<br/>HIV Infections--therapy<br/>HIV-1--genetics<br/>HeLa Cells<br/>Humans<br/>Models, Genetic<br/>Plasmids--metabolism<br/>Ribonucleases--metabolism<br/>Simplexvirus--genetics<br/>Tetrazolium Salts--pharmacology<br/>Thiazoles--pharmacology<br/>Thymidine Kinase--genetics<br/>Time Factors